MEDICINE & HEALTH

Nerivio from Theranica

Revolutionizing Migraine Care: Dr. Reddy's Laboratories Launches Nerivio, the Innovative Wearable Therapy Device in India

In a move that could potentially change the landscape of migraine treatment, Dr. Reddy's Laboratories (NSE: DRREDDY), a renowned name in the global pharmaceutical industry, has unveiled Nerivio in India. This innovative wearable therapy device, approved by the United States Food and Drug Administration (USFDA), introduces a non-invasive approach to managing migraines, a condition that affects an estimated 30% of adults worldwide. The launch of Nerivio not only reflects Dr. Reddy's commitment to advancing healthcare through innovation but also marks a significant milestone in the company's expanding portfolio of therapeutic solutions.

Recommended Stories